Abstract
It is an unfortunate reality that many patients with solid tumors initially sensitive to anticancer chemotherapy subsequently develop recurrences that resist further treatment with these agents. This problem has fostered research efforts to define the mechanisms of resistance and to determine strategies to circumvent them. cis-diamminedichloroplatinum II (cDDP) is widely used in a variety of solid tumors and has dramatically altered the survival of young men with germ-cell tumors of the testis. It also has utility in treating epithelial cancers of the head and neck and bladder, as well as in the therapy of ovarian tumors. Despite this success, the problem of intrinsic and acquired resistance to cDDP is important, and strategies to reverse it would be immensely beneficial. In the following review we will outline the role metallothionein may have in cytotoxic drug resistance, with an emphasis on its possible involvement in resistance to cDDP.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Margoshes, M. and Vallee, B.L. A cadmium protein from equine kidney cortex. J. Am. Chem. Soc. 79:4813–4814, 1957.
Kagi, J.H.R. and Vallee, B.L. Metallothionein: a cadmium-and zinc-containing protein from equine renal cortex. J. Biol. Chem. 235:3460–3465, 1960.
Hamer, D.H. Metallothionein. Annu. Rev. Biochem. 55:913–951, 1986.
Danielson, K.G., Ohi, S., and Huang, P.C. Immunochemical detection of metallothionein in specific epithelial cells of rat organs. Proc. Natl. Acad. Sci. USA 79:2301–2304, 1982.
Banerjee, D., Onosaka, S., and Cherian, M.G. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 24: 95–105, 1982.
Piscator, M. On cadmium in normal human kidneys together with a report on the isolation of metallothionein from livers of cadmium-exposed rabbits. Nord. Hyg. Tidskr. 45:76–82, 1964.
Durnam, D.M. and Palmiter, R.D. Transcriptional regulation of the mouse metallothionein-I gene by heavy metals. J. Biol. Chem. 256:5712–5716, 1981.
Schmidt, C.J. and Hamer, D.H. Cell specificity and an effect of ras on human metallothionein gene expression. Proc. Natl. Acad. Sci. USA 83:3346–3350, 1986.
Richards, R.I., Heguy, A., and Karin, M. Structural and functional analysis of the human metallothionein-IA gene: differential induction by metal ions and glucocorticoids. Cell 37:263–272, 1984.
Sadhu, C. and Gedamu, L. Regulation of human metallothionein genes. J. Biol. Chem. 263:2679–2684, 1988.
Karin, M., Haslinger, A., Holtgreve, H., Richards, R., and Krauter, P. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 308:513–519, 1984.
Searle, P., Stuart, G.W., and Palmiter, R.D. Building a metal-responsive promoter with synthetic regulatory elements. Mol. Cell. Biol. 5:1480–1489, 1985.
Imbert, J., Zafrullah, M., Culotta, V.C., Gedamu, L., and Hamer, D.H. Transcription factor MBF-I interacts with metal regulatory elements of higher eucaryotic metallothionein genes. Mol. Cell. Biol. 9:5315–5323, 1989.
Ryden, L. and Deutsch, H.F. Preparation and properties of the major copper binding component in human fetal liver, its identification as metallothionein. J. Biol. Chem. 253:519–524, 1978.
Failla, M.L. and Cousins, R.J. Zinc uptake by rat liver parenchymal cells. Biochem. Biophys. Acta 538:435–444, 1978.
Hager, L.J. and Palmiter, R.D. Transcriptional regulation of mouse liver metallothionein-I gene by glucocorticoids. Nature 291:340–343, 1981.
Cousins, R.J. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol. Rev. 65:238–309, 1985.
Durnam, D.M., Hoffman, J.S., Quaife, C.J., Benditt, E.P., Chen, H.Y., Brinster, R.L., and Palmiter, R.D. Induction of mouse metallothionein-I mRNA by bacterial endotoxin is independent of metals and glucocorticoid hormones. Proc. Natl. Acad. Sci. USA 81: 1053–1056, 1984.
Friedman, R.L., Manly, N., McMahon, N., Kerr, I.M., and Stark, G.R. Transcriptional regulation of interferon-induced gene expression in human cells. Cell 38:745–755, 1984.
Karin, M., Imbra, R.J., Heguy, A., and Wong, G. Interleukin I regulates human metallothionein gene expression. Mol. Cell. Biol. 5:2866–2869, 1985.
Cousins, R.J. and Leinhart, A.S. Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1._FASEB J. 2:2884–2890, 1988.
Shiraishi, N., Aono, K., and Utsumi, K. Increased metallothionein content in rat liver induced by x-irradiation and exposure to high oxygen tension. Radiat. Res. 95:298–302, 1983.
Shiraishi, N., Yammamoto, Y., Takeda, Y., Kondoh, S., Hayashi, H., Hashimoto, K., and Aono, K. Increased metallothionein content in rat liver and kidney following x-irradiation. Toxicol. Appl. Pharmacol. 85:128–134, 1986.
Koropatnick, J., Leibbrandt, M., and Cherian, M.G. Organ-specific metallothionein induction in mice by x-irradiation. Radiat. Res. 119:356–365, 1989.
Karin, M. Metallothioneins: proteins in search of function. Cell 41:9–10, 1985.
Compere, S.J. and Palmiter, R.D. DNA methylation controls the inducibility of the mouse metallothionein I gene in lymphoid cells. Cell 25:233–240, 1981.
Durnam, D.M. and Palmiter, R.D. Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: evidence for gratuitous inducers. Mol. Cell. Biol. 4: 484–491, 1984.
Beach, L.R. and Palmiter, R.D. Amplification of the metallothionein-I gene in cadmium resistant mouse cells. Proc. Natl. Acad. Sci. USA 78:2110–2114, 1981.
Gick, G.G. and McCarty, K.S. Amplification of the metallothionein-I gene in cadmium-and zinc-resistant Chinese hamster ovary cells. J. Biol. Chem. 257:9049–9053, 1982.
Schmidt, C.J., Jubier, M.-F., and Hamer, D.H. Structure and expression of two human metallothioncin-I isoform genes and a related pseudogene. J. Biol. Chem. 260:7731–7737, 1985.
Karin, M., Cathala, G., and Nguyen-Huu, M.C. Expression and regulation of a human metallothionein gene carried on an autonomously replicating shuttle vector. Proc. Natl. Acad. Sci. USA 80:4040–4044, 1983.
Kagi, J.H.R. and Schaffer, A. Biochemistry of metallothionein. Biochemistry 27:8509–8515, 1988.
Brewer, G.J., Hill, G.M., Prasad, A.S., Cossack, Z.T., and Rabani, P. Oral zinc therapy for Wilson’ s disease. Ann. Intern. Med. 99:314–320, 1983.
Klug, A. and Rhodes, D. “ Zinc fingers”: A novel protein motif for nucleic acid recognition. Trends Biochem. Sci. 12:464–469, 1987.
Ohtake, H., Hasegawa, K., and Koga, M. Zinc-binding protein in the liver of neonatal, normal, and partially hepatectomized rats. Biochem. J. 174:999–1005, 1978.
Nemer, M., Travaglini, E.C., Rondinelli, E., and D’Alonzo, J. Developmental regulation, induction, and embryonic tissue specificity of sea urchin metallothionein gene expression. Dev. Biol. 102:471–482, 1984.
Andrews, G.K., Adamson, E.D., and Gedamu, L. The ontogeny of expression of murine metallothionein: comparison with the a-fetoprotein gene. Dev. Biol. 103:294–303, 1984.
Bakka, A., Samarawickrama, G.P., and Webb, M. Metabolism of zinc and copper in the neonate: effect of cadmium administration during late gestation in the rat on the zinc and copper metabolism of the newborn. Chem. Biol. evidenceact. 34:161–171, 1981.
Wilkinson, D.G. and Nemer, M. Metallothionein genes MTa and MTb expressed under distinct quantitative and tissue-specific regulation in sea urchin embryos. Mol. Cell. Biol. 7:48–58, 1987.
Thornalley, P.J. and Vasek, M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with Superoxide and hydroxyl radicals. Biochem. Biophys. Acta 827:36–44, 1985.
Dunn, M.A., Blalock, T.L., and Cousins, R.J. Metallothionein. Proc. Soc. Exp. Biol. Med. 185:107–119, 1987.
Matsubara, J., Tajima, Y., Ikeda, A., Kinoshita, T., and Shimoyama, T. A new perspective of radiation protection by metallothionein induction. Pharmac. Ther. 39:331–333, 1988.
Shiraishi, N., Hayashi, H., Hiraki, Y., Aono, K., Itano, Y., Kosaka, F., Noji, S., and Taniguchi, S. Elevation in metallothionein messenger RNA in rat tissues after exposure to x-irradiation. Toxicol. Appl. Pharmacol. 98:501–506, 1989.
Lohrer, H. and Robson, T. Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents. Carcinogenesis 10:2279–2284, 1989.
Bakka, A., Endresen, L., Johnsen, A.B.S., Edminson, P.D., and Rugstad, H.E. Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol. Appl. Pharmacol. 61:215–226, 1981.
Kelley, S.L., Basu, A., Teicher, B.A., Hacker, M.P., Hamer, D.H., and Lazo, J.S. Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813–1815, 1988.
Teicher, B.A., Holden, S.A., Kelley, M.J., Shea, T.C., Cucchi, CA., Rosowsky, A., Henner, W.D., and Frei, E., III. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum II. Cancer Res. 47:388–393, 1987.
Andrews, P.A., Murphy, M.P., and Howell, S.B. Metallothionein mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother. Pharmacol. 19:149–154, 1987.
Endresen, L., Schjerven, L., and Rugstad, H.E. Tumours from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum. Acta Pharmacol. Toxicol. 55:183–187, 1984.
Endresen, L., Bakka, A., and Rugstad, H.E. Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res. 43: 2918–2926, 1983.
Webber, M.M., Maseehur Rehman, S.M., and James, G.T. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin. Cancer Res. 48:4503–4508, 1988.
Zelazowski, A.J., Garvey, J.S., and Hoeschele, J.D. In vivo and in vitro binding of platinum to metallothionein. Arch. Biochem. Biophys. 229:246–252, 1984.
Kraker, A., Schmidt, J., Krezoski, S., and Petering, D.H. Binding of cis-dichlorodiammineplatinum II to metallothionein in Ehrlich cells. Biochem. Biophys. Res. Commun. 130:786–792, 1985.
Chin, J.L., Banerjee, D., Kadhim, S., and Cherian, G. Role of metallothioneins in germ cell tumor behavior: preliminary experimental and clinical evidence. J. Urol. 143:265A, 1990.
Naganuma, A., Satoh, M., and Imura, N. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum (II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res. 47:983–987, 1987.
Naganuma, A., Satoh, M., and Imura, N. Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. Jpn. J. Cancer Res. 79:406–411, 1988.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bahnson, R.R., Basu, A., Lazo, J.S. (1991). The role of metallothioneins in anticancer drug resistance. In: Ozols, R.F. (eds) Molecular and Clinical Advances in Anticancer Drug Resistance. Cancer Treatment and Research, vol 57. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3872-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3872-1_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6726-0
Online ISBN: 978-1-4615-3872-1
eBook Packages: Springer Book Archive